Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFβ and its receptor, TGFβRII
- 30 December 2005
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (6) , 632-650
Abstract
BACKGROUND The underlying mechanisms permitting prostate cancer bone metastasis are poorly understood. We previously showed that the highly metastatic prostate cancer cell line, PC-3, inhibits bone marrow endothelial (HBME-1) cell growth in collagen gels and induces them to differentiate into cords, resembling angiogenesis in vivo. METHODS cDNA microarray analysis was performed to identify cytokines responsible for the effects of PC-3 cells on HBME-1 cells. Cytokine and neutralizing antibody studies were done to further investigate specific angiogenic factors, such as transforming growth factor β (TGFβ). TGFβ RNA and protein were detected by real-time RT-PCR and enzyme-linked immunosorbent assay (ELISA) analysis to measure their production by prostate cancer cell lines. Conditioned media experiments using TGFβ neutralizing antibodies were used to analyze TGFβ activation by prostate cancer cells. RESULTS PC-3 conditioned media altered the expression of several TGFβ-regulated or -associated genes in HBME-1 cells. Low concentrations of TGFβ cytokines inhibited HBME-1 cell growth to a similar level as PC-3 conditioned media and partially induced differentiation. Inhibitors and neutralizing antibodies directed against TGFβ isoforms and TGFβ receptor type 2 (TGFβRII) reversed the growth inhibition of HBME-1 cells conferred by PC-3 conditioned media. Yet, only TGFβRII neutralizing antibodies significantly inhibited HBME-1 differentiation. Also, prostate cancer cell lines produced low levels of TGFβ RNA and protein, and were shown to activate serum-derived TGFβ. CONCLUSIONS These results suggest that prostate cancer cells mediate growth inhibition and differentiation of bone marrow endothelial cells both through production and activation of TGFβ as well as alteration of TGFβRII-mediated signal transduction. This could contribute to the establishment and growth of bone metastases. Prostate 66:632–650, 2006.Keywords
This publication has 37 references indexed in Scilit:
- Bi‐directional interactions of prostate cancer cells and bone marrow endothelial cells in three‐dimensional cultureThe Prostate, 2005
- Advances in prostate cancerCurrent Opinion in Oncology, 2004
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- Cellular interactions in the tropism of prostate cancer to boneInternational Journal of Cancer, 2004
- Angiogenesis and prostate cancer tumor growthJournal of Cellular Biochemistry, 2003
- Dynamic process of prostate cancer metastasis to boneJournal of Cellular Biochemistry, 2003
- Interference with TGF‐β1 and ‐β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinomaInternational Journal of Cancer, 2002
- Ultraviolet Irradiation Alters Transforming Growth Factor β/Smad Pathway in Human Skin In VivoJournal of Investigative Dermatology, 2002
- INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINEJournal of Urology, 2000
- Endothelial cell regulation by transforming growth factor‐betaJournal of Cellular Biochemistry, 1991